Wall Street backs new class of psychedelic drugs

Psychedelic-therapy industry gets a reality trip as investors focus on treatments costing less time and money.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...